The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
6-nitro-2-(((1-(4-chlorophenyl)-1H-1,2,3-triazol-4-yl)methyl)thio)-4H-benzo[e][1,3]thiazin-4-one ID: ALA5205643
PubChem CID: 168296208
Max Phase: Preclinical
Molecular Formula: C17H10ClN5O3S2
Molecular Weight: 431.89
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: O=c1nc(SCc2cn(-c3ccc(Cl)cc3)nn2)sc2ccc([N+](=O)[O-])cc12
Standard InChI: InChI=1S/C17H10ClN5O3S2/c18-10-1-3-12(4-2-10)22-8-11(20-21-22)9-27-17-19-16(24)14-7-13(23(25)26)5-6-15(14)28-17/h1-8H,9H2
Standard InChI Key: ZXCJDHVCFAHSCS-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 31 0 0 0 0 0 0 0 0999 V2000
2.2269 -1.0190 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.0474 -0.9328 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5322 -1.6003 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3526 -1.5140 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6882 -0.7604 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5086 -0.6742 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
4.2032 -0.0930 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3828 -0.1792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.6749 -0.4060 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.9213 -0.7415 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2069 -0.3291 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.5074 -0.7415 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
-1.2219 -0.3291 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2219 0.4958 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.9363 0.9083 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.9363 1.7332 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-2.6508 0.4958 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.6508 -0.3291 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.3652 -0.7415 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.0796 -0.3291 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.0796 0.4958 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.3652 0.9083 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.9363 -0.7415 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
1.0075 -1.5620 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.8144 -1.7335 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-4.7941 0.9083 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-4.7941 1.7335 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-5.5086 0.4957 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 1 0
5 7 2 0
8 2 2 0
7 8 1 0
9 1 1 0
9 10 2 0
11 10 1 0
12 11 1 0
13 12 1 0
13 14 2 0
14 15 1 0
15 16 2 0
17 15 1 0
18 17 2 0
19 18 1 0
20 19 2 0
21 20 1 0
17 22 1 0
22 21 2 0
18 23 1 0
23 13 1 0
24 10 1 0
25 24 2 0
1 25 1 0
21 26 1 0
26 27 1 0
26 28 2 0
M CHG 2 26 1 27 -1
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 431.89Molecular Weight (Monoisotopic): 430.9914AlogP: 4.09#Rotatable Bonds: 5Polar Surface Area: 103.81Molecular Species: NEUTRALHBA: 9HBD: ┄#RO5 Violations: ┄HBA (Lipinski): 8HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: ┄CX LogP: 4.60CX LogD: 4.60Aromatic Rings: 4Heavy Atoms: 28QED Weighted: 0.27Np Likeness Score: -2.57
References 1. Sahoo SK, Ahmad MN, Kaul G, Nanduri S, Dasgupta A, Chopra S, Yaddanapudi VM.. (2022) Synthesis and evaluation of triazole congeners of nitro-benzothiazinones potentially active against drug resistant Mycobacterium tuberculosis demonstrating bactericidal efficacy., 13 (5.0): [PMID:35694687 ] [10.1039/d1md00387a ]